Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

BSX - BOSTON SCIENTIFIC CORP


104.97
-0.130   -0.124%

Share volume: 10,639,085
Last Updated: Wed 05 Feb 2025 10:00:00 PM CET
Surgical and Medical Instrument Manufacturing : -0.22%

PREVIOUS CLOSE
CHG
CHG%

$105.10
1.43
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
54%
Profitability 44%
Dept financing 47%
Liquidity 17%
Performance 76%
Company vs Stock growth
vs
Performance
5 Days
1.84%
1 Month
14.99%
3 Months
21.44%
6 Months
42.31%
1 Year
62.02%
2 Year
120.25%
Key data
Stock price
$104.97
P/E Ratio 
68.86
DAY RANGE
$102.44 - $107.17
EPS 
$1.25
52 WEEK RANGE
$64.54 - $107.17
52 WEEK CHANGE
$61.44
MARKET CAP 
123.406 B
YIELD 
N/A
SHARES OUTSTANDING 
1.473 B
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.68
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$7,307,211
AVERAGE 30 VOLUME 
$6,637,024
Company detail
CEO: Michael F. Mahoney
Region: US
Website: bostonscientific.com
Employees: 45,000
IPO year: 1992
Issue type: Common Stock
Market: NYSE
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions.

Recent news